Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Falling Comet
1294.8500 -64.70 (-4.76%)
NSE Apr 09, 2025 15:31 PM
Volume: 425.8K
 

1294.85
-4.76%
Prabhudas Lilladhar
Q4FY22/Q1FY23. Domestic business (45% of total sales) continues to remain on strong footing and should continue to outperform IPM. Strong API capabilities and diversified model benefit IPCA in the current environment. We recommend Buy' rating on the stock with target price of Rs 2,450 based...
Ipca Laboratories Ltd. has lost -23.56% in the last 3 Months
More from Ipca Laboratories Ltd.
Recommended